0001104659-20-061243.txt : 20200514
0001104659-20-061243.hdr.sgml : 20200514
20200514091836
ACCESSION NUMBER: 0001104659-20-061243
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200514
DATE AS OF CHANGE: 20200514
EFFECTIVENESS DATE: 20200514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 20875557
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
03-31-2020
03-31-2020
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
05-14-2020
0
6
428291
INFORMATION TABLE
2
infotable.xml
10x Genomics, Inc.
CLASS A COMMON
88025U109
410518
6587253
SH
SOLE
6587253
0
0
Acceleron Pharma Inc.
COM
00434H108
3126
34784
SH
SOLE
34784
0
0
Aerie Pharmaceuticals, Inc.
COM
00771V108
3425
253698
SH
SOLE
253698
0
0
Epizyme, Inc.
COM
29428V104
5894
379981
SH
SOLE
379981
0
0
Insmed Incorporated
COM
457669307
3792
236547
SH
SOLE
236547
0
0
REGENXBIO Inc.
COM
75901B107
1536
47443
SH
SOLE
47443
0
0